Identification of differentially expressed MicroRNAs in endometrial cancer cells after progesterone treatment

International Journal of Gynecological Cancer

Volumn 22, Issue 4, 2012, Pages 561-565

  Bae, Jeehyeon ^a   Won, Miae ^b   Kim, Dae Yeon ^c   Kim, Jong Hyeok ^c   Kim, Yong Man ^c   Kim, Young Tak ^c   Nam, Joo Hyun ^c   Suh, Dae Shik ^c  

^a Chung Ang University   (South Korea)

^b CHA University   (South Korea)

^c University of Ulsan   (South Korea)

Author keywords

Endometrial cancer; MiRNA; Progesterone

Indexed keywords

MEDROXYPROGESTERONE ACETATE; MICRORNA; MICRORNA 142 5P; MICRORNA 146 5P; MICRORNA 193B; MICRORNA 21; MICRORNA 29; MICRORNA 29C; MICRORNA 625; MICRORNA 633; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CANCER HORMONE THERAPY; CANCER REGRESSION; CARCINOMA CELL; CONTROLLED STUDY; DOWN REGULATION; ENDOMETRIUM CARCINOMA; ENDOMETRIUM CELL; GENE EXPRESSION; GENE TARGETING; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION;

CELL LINE, TUMOR; ENDOMETRIAL NEOPLASMS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGESTERONE; PROGESTINS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 84863681579     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0b013e31824927db     Document Type: Article

References (19)

1. Evans-Metcalf ER, Brooks SE, Reale FR, et al. Profile of women 45 years of age and younger with endometrial cancer. Obstet Gynecol. 1998;91:349-354.
2. Ramirez PT, Frumovitz M, Bodurka DC, et al. Hormonal therapy for the management of grade 1 endometrial adenocarcinoma: a literature review. Gynecol Oncol. 2004;95:133-138.
3. Daayana S, Holland CM. Hormone replacement therapy and the endometrium. Menopause Int. 2009;15:134-138.
4. Lee SK, Calin GA. Non-coding RNAs and cancer: new paradigms in oncology. Discov Med. 2010;11:245-254.
5. Pan Q, Chegini N. MicroRNA signature and regulatory functions in the endometrium during normal and disease states. Semin Reprod Med. 2008;26:479-493.
6. Boren T, Xiong Y, Hakam A, et al. MicroRNAs and their target messenger RNAs associated with endometrial carcinogenesis. Gynecol Oncol. 2008;110:206-215.
7. Cohn DE, Fabbri M, Valeri N, et al. Comprehensive miRNA profiling of surgically staged endometrial cancer. Am J Obstet Gynecol. 2010;202:656.e1-656. e8.
8. Chung TK, Cheung TH, Huen NY, et al. Dysregulated microRNAs and their predicted targets associated with endometrioid endometrial adenocarcinoma in Hong Kong women. Int J Cancer. 2009;124:1358-1365.
9. Wu W, Lin Z, Zhuang Z, et al. Expression profile of mammalian microRNAs in endometrioid adenocarcinoma. Eur J Cancer Prev. 2009;18:50-55.
10. Yang S, Thiel KW, Leslie KK. Progesterone: the ultimate endometrial tumor suppressor. Trends Endocrinol Metab. 2011;22:145-152.
11. Pan Q, Luo X, Toloubeydokhti T, et al. The expression profile of micro-RNA in endometrium and endometriosis and the influence of ovarian steroids on their expression. Mol Hum Reprod. 2007;13:797-806.
12. Toloubeydokhti T, Pan Q, Luo X, et al. The expression and ovarian steroid regulation of endometrial micro-RNAs. Reprod Sci. 2008;15:993-1001.
13. Kuokkanen S, Chen B, Ojalvo L, et al. Genomic profiling of microRNAs and messenger RNAs reveals hormonal regulation in microRNA expression in human endometrium. Biol Reprod. 2010;82:791-801.
14. Sha AG, Liu JL, Jiang XM, et al. Genome-wide identification of microYribonucleic acids associated with human endometrial receptivity in natural and stimulated cycles by deep sequencing. Fertil Steril. 2011;96:150-155.e5.
15. Cai X, Hagedorn CH, Cullen BR. Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs. RNA. 2004;10:1957-1966.
16. Pan X, Wang ZX, Wang R. MicroRNA-21: a novel therapeutic target in human cancer. Cancer Biol Ther. 2010;10:1224-1232.
17. Li J, Huang H, Sun L, et al. MiR-21 indicates poor prognosis in tongue squamous cell carcinomas as an apoptosis inhibitor. Clin Cancer Res. 2009;15:3998-4008.
18. Rossi S, Shimizu M, Barbarotto E, et al. microRNA fingerprinting of CLL patients with chromosome 17p deletion identify a miR-21 score that stratifies early survival. Blood. 2010;116:945-952.
19. Kim YJ, Hwang SJ, Bae YC, et al. MiR-21 regulates adipogenic differentiation through the modulation of TGF-beta signaling in mesenchymal stem cells derived from human adipose tissue. Stem Cells. 2009;27:3093-3102.